- Home
- MNOV
MNOV
Medicinova Inc
as 11-20-2025 9:38am EST
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | LA JOLLA |
| Market Cap: | 76.0M | IPO Year: | 2005 |
| Target Price: | $7.00 | AVG Volume (30 days): | 3.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.24 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.13 - $2.48 | Next Earning Date: | 11-12-2025 |
| Revenue: | $257,917 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Medicinova Inc News
MNOV Breaking Stock News: Dive into MNOV Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor
Associated Press Finance
8 days ago
MediciNova: Q3 Earnings Snapshot
GlobeNewswire
14 days ago
MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards
GlobeNewswire
16 days ago
MediciNova Announces Completion of Patient Enrollment in MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
Simply Wall St.
17 days ago
3 Penny Stocks With Market Caps Over $80M To Consider
TipRanks
20 days ago
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis
GlobeNewswire
21 days ago
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication
GlobeNewswire
a month ago
MediciNova to Present at the LD Micro Main Event XIX Investor Conference
Compare MNOV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MNOV Medicinova Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.